280. Huge arteriovenous malformation with cervicofacial or limb lesion
22 clinical trials,   26 drugs   (DrugBank: 13 drugs),   11 drug target genes,   147 drug target pathways

Searched query = "Huge arteriovenous malformation with cervicofacial or limb lesion", "Huge arteriovenous malformation", "Arteriovenous malformation"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
4 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1ChiCTR2000036597
2020-10-012020-08-24The safety and efficacy of embolization of jaw arteriovenous malformations: one center observational studyThe safety and efficacy of embolization of jaw arteriovenous malformations: one center observational study jaw arteriovenous malformationsgroup of bleeding:coils and absolute ethanol;group of no bleeding:coils and absolute ethanol;Shanghai Ninth People Hospital, School of Medicine, Shanghai Jiaotong UniversityNULLPending515Bothgroup of bleeding:30;group of no bleeding:30;N/AChina
2ChiCTR2000036576
2020-09-012020-08-24A randomized controlled trial for comparing the effect and outcomes with different embolic agent: Absolute Ethanol and Onyx in the treatment of AVMA randomized controlled trial for comparing the effect and outcomes with different embolic agent: Absolute Ethanol and Onyx in the treatment of AVM arteriovenous malformationsGroup 1:absolute ethanol;Group 2:Oynx;Shanghai Ninth People Hospital, School of Medicine, Shanghai Jiaotong UniversityNULLRecruitingBothGroup 1:30;Group 2:30;N/AChina
3ChiCTR1800017616
2018-08-062018-08-06A randomized controlled trial for comparing the effect and outcomes with different embolic agent: Absolute ethanol, Onyx and n-BCA in the treatment of AVMA randomized controlled trial for comparing the effect and outcomes with different embolic agent: Absolute ethanol, Onyx and n-BCA in the treatment of AVM arteriovenous malformationsEthanol group:Embolization with ethanol;Onyx group:Embolization with Onyx;n-BCA group:Embolization with n-BCA;Shanghai 9th People's Hospital, Shanghai Jiaotong University School of MedicineNULLRecruitingBothEthanol group:30;Onyx group:30;n-BCA group:30;China
4ChiCTR1800015220
2018-03-142018-03-15Prospective evaluation of embolization with absolute alcohol in the treatment of arteriovenous malformationsProspective evaluation of embolization with absolute alcohol in the treatment of arteriovenous malformations arteriovenous malformationsEthanol group:Embolization with absolute ethanol;Shanghai 9th People's Hospital, Shanghai Jiaotong University School of MedicineNULLRecruitingBothEthanol group:30;China